Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and ...

AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications ...

Blockchain has numerous potential benefits for healthcare, which is the topic of episode three in the Blockchain in Scotland ...

The NSW government has announced an investment of A$20.7m ($13.39m) aimed at providing access to life-changing therapies.

Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule ...

Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Draig Therapeutics has secured £107m ($140m) in an oversubscribed Series A financing round to treat major neuropsychiatric ...